AI blood test could revolutionize lung cancer detection

NCT ID NCT07460440

Summary

This study is testing a new blood test that uses artificial intelligence to analyze RNA from platelets to detect lung cancer. Researchers will enroll 240 people, including those with lung nodules or newly diagnosed lung cancer, to see if this test can accurately tell cancerous from non-cancerous growths. The goal is to develop a less invasive way to diagnose lung cancer early.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Utah

    Salt Lake City, Utah, 84112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.